ReportGemReportGem 中文

PUBLIC COMPANY RESEARCH HUB

Cigna Group (CI) Filings, Earnings Calls and Research

A source-backed research workspace for Cigna Group. Compare recent disclosures, management commentary and foreign research coverage without losing the original evidence trail.

Evidence documents6
Filings6
Meetings0
Research0
Displayed research share0%
Latest evidence2026-05-13

Primary-source evidence

8-K2026-05-13 · SEC EDGAR · 8-K

Cigna Group filed an 8-K on May 13, 2026, reaffirming its full-year 2026 adjusted income from operations outlook of at least $30.35 per share. The outlook was previously disclosed on April 30, 2026, and will be reiterated in upcoming investor meetings.…

10-Q2026-04-30 · SEC EDGAR · 10-Q

Cigna Group reported Q1 2026 total revenues of $68.5 billion, up 5% YoY, and net income of $1.86 billion, up 32%. Shareholders' net income rose 25% to $1.65 billion. Adjusted income from operations increased 12% to $2.06 billion.…

8-K2026-03-03 · SEC EDGAR · 8-K

Cigna Group announced CEO succession on Feb 25, 2026: Brian C. Evanko, current President and COO, will become CEO on July 1, 2026, succeeding David M. Cordani, who will retire and become Executive Chair.…

8-K2026-02-27 · SEC EDGAR · 8-K

Cigna Group filed an 8-K on Feb 27, 2026, reaffirming its 2026 adjusted EPS outlook of at least $30.25. The outlook was previously disclosed on Feb 5, 2026, and will be reiterated in upcoming investor meetings.…

10-K2026-02-26 · SEC EDGAR · 10-K

Cigna Group's 2025 revenue rose 11% to $274.9B, with shareholders' net income up 73% to $5.957B, driven by absence of 2024 VillageMD impairment. Adjusted income from operations grew 4% to $8.014B.…

10-Q2025-10-30 · SEC EDGAR · 10-Q

Cigna Group's Q3 2025 revenues rose 10% to $69.7B, with shareholders' net income up 153% to $1.87B, driven by absence of 2024 VillageMD impairment. Adjusted EPS was $7.83, up 4%. Medical customers decreased 5% due to HCSC transaction closing.…

Questions this evidence can help answer

  • What changed in the latest research coverage of Cigna Group?
  • Which operating and valuation themes recur across institutions?
  • Which claims should be checked against company primary-source evidence?
Research this company with AI